Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 22, 2015 12:45 AM ET

Commercial Services and Supplies

Company Overview of Juvenile Diabetes Research Foundation International Inc.

Company Overview

Juvenile Diabetes Research Foundation International Inc. (JDRF) is a not-for-profit organization that focuses on juvenile diabetes cure research and development services. The organization offers grants for diabetes clinical trials to laboratories, educational institutions, and pharmaceutical and medical research companies. JDRF was founded in 1970 and is headquartered in New York City with an additional office in Houston, Texas.

120 Wall Street

19th Floor

New York, NY 10005-4001

United States

Founded in 1970

Phone:

212-479-7551

Fax:

212-785-9595

Key Executives for Juvenile Diabetes Research Foundation International Inc.

Chief Executive Officer, President and Director
Chief Financial Officer
Executive Vice President for Development and Chief Operating Officer
Vice President-Customer Services
President of Long Island Chapter
Compensation as of Fiscal Year 2014.

Juvenile Diabetes Research Foundation International Inc. Key Developments

Selecta Biosciences, Inc., JDRF and Sanofi Extends Collaboration to Develop Synthetic Vaccine Particle Immunotherapy for Type 1 Diabetes

Selecta Biosciences, Inc., and JDRF, announced that they have extended their joint research collaboration and attracted Sanofi as a partner in support of their program to develop a Synthetic Vaccine Particle (SVP) immunotherapy with the long-term goal to treat and potentially prevent the underlying cause of type 1 diabetes. This collaborative research program is aimed at accelerating the advancement of an SVP immunotherapy designed to reset the immune system and restore tolerance to substances (antigens) that cause the immune attacks on insulin-producing cells in the pancreas. Selectas proprietary tolerogenic SVP products show potential to re-educate the immune system to stop or suppress pro-inflammatory responses against a specific antigen, thereby halting the undesirable immune reaction without causing harmful global immune suppression common with general immune system modulating drugs. As part of their collaboration, JDRF and Sanofi are co-financing the program with the aim of advancing the SVP product candidate to the clinic. This next phase of the SVP development program has been structured as a grant award to Selecta in order to test up to four antigens that may succeed in stopping the autoimmune response that destroys beta cells. JDRF has a strategic research plan designed to deliver a sustained stream of new, life-changing therapies.

JDRF Supports Janssen's Disease Interception Approach to Prevent the Clinical Onset of Type 1 Diabetes

JDRF announced its alignment with an innovative scientific approach of Janssen Research & Development, LLC and the company's Disease Interception Accelerator (DIA) group, which will focus on transforming type 1 diabetes through its disease interception strategy. JDRF will work with Janssen scientists to further identify the root cause(s) of T1D with the aim of intercepting and eliminating the disease before clinical symptoms emerge, effectively seeking to create a new paradigm in health care for T1D.

JDRF Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 11:30 AM

JDRF Presents at 17th Annual BIO CEO & Investor Conference, Feb-09-2015 11:30 AM. Venue: The Waldorf Astoria, New York, New York, United States.

Similar Private Companies By Industry

Company Name Region
Holo-Source Corporation United States
Incuborn Solutions, Inc. United States
Kidspeace National Centers For Kids In Crisis Of New England (Inc) United States
Peak6 Futures Holdings, LLC United States
Sheridan Printing Company, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Juvenile Diabetes Research Foundation International Inc., please visit www.jdrf.org. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.